Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5701125 | European Journal of Surgical Oncology (EJSO) | 2016 | 8 Pages |
Abstract
MVI in the resected specimen of patients with HCC is associated with a poor prognosis. A preoperative MVI prediction model offers a useful way to identify patients at risk of relapse. However, more precise predictive models using molecular and genetic variables are needed to improve selection of patients most suitable for radical surgical treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S.M. Schlichtemeier, T.C. Pang, N.E. Williams, A.J. Gill, R.C. Smith, J.S. Samra, V.W.T. Lam, M. Hollands, A.J. Richardson, H.C. Pleass, S. Nozawa, M. Albania, T.J. Hugh,